Articles with public access mandates - Nancy L. HaigwoodLearn more
Not available anywhere: 2
Tied down by its own receptor
NL Haigwood
Nature 519 (7541), 36-37, 2015
Mandates: US National Institutes of Health
P-D10 Differential induction of anti-V3 crown antibodies with cradle and ladle-binding modes in response to HIV-1 envelope vaccination
P Balasubramanian, R Kumar, C Williams, V Itri, S Wnag, S Lu, A Hesell, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 71, 96, 2016
Mandates: US National Institutes of Health
Available somewhere: 68
Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques
AJ Hessell, JP Jaworski, E Epson, K Matsuda, S Pandey, C Kahl, J Reed, ...
Nature medicine 22 (4), 362-368, 2016
Mandates: US National Institutes of Health
Human natural killer cells mediate adaptive immunity to viral antigens
R Nikzad, LS Angelo, K Aviles-Padilla, DT Le, VK Singh, L Bimler, ...
Science immunology 4 (35), eaat8116, 2019
Mandates: US National Institutes of Health, UK Medical Research Council
Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques
CT Ng, JP Jaworski, P Jayaraman, WF Sutton, P Delio, LR Kuller, ...
Nature medicine 16 (10), 1117-1119, 2010
Mandates: US National Institutes of Health
Use of broadly neutralizing antibodies for HIV‐1 prevention
A Pegu, AJ Hessell, JR Mascola, NL Haigwood
Immunological reviews 275 (1), 296-312, 2017
Mandates: US National Institutes of Health
Continuous viral escape and selection by autologous neutralizing antibodies in drug-naive human immunodeficiency virus controllers
M Mahalanabis, P Jayaraman, T Miura, F Pereyra, EM Chester, ...
Journal of virology 83 (2), 662-672, 2009
Mandates: US National Institutes of Health
High specific infectivity of plasma virus from the pre-ramp-up and ramp-up stages of acute simian immunodeficiency virus infection
ZM Ma, M Stone, M Piatak Jr, B Schweighardt, NL Haigwood, D Montefiori, ...
Journal of virology 83 (7), 3288-3297, 2009
Mandates: US National Institutes of Health
The use of nonhuman primate models in HIV vaccine development
C Morgan, M Marthas, C Miller, A Duerr, C Cheng-Mayer, R Desrosiers, ...
PLoS medicine 5 (8), e173, 2008
Mandates: US National Institutes of Health
Vaccine delivery to the oral cavity using coated microneedles induces systemic and mucosal immunity
Y Ma, W Tao, SJ Krebs, WF Sutton, NL Haigwood, HS Gill
Pharmaceutical research 31, 2393-2403, 2014
Mandates: US National Institutes of Health
Sequential immunization with a subtype B HIV-1 envelope quasispecies partially mimics the in vivo development of neutralizing antibodies
DC Malherbe, NA Doria-Rose, L Misher, T Beckett, WB Puryear, ...
Journal of virology 85 (11), 5262-5274, 2011
Mandates: US National Institutes of Health
The critical role of nonhuman primates in medical research
H Friedman, N Ator, N Haigwood, W Newsome, JS Allan, TG Golos, ...
Pathogens & immunity 2 (3), 352, 2017
Mandates: US National Institutes of Health
A meta-analysis of passive immunization studies shows that serum-neutralizing antibody titer associates with protection against SHIV challenge
A Pegu, B Borate, Y Huang, MG Pauthner, AJ Hessell, B Julg, ...
Cell host & microbe 26 (3), 336-346. e3, 2019
Mandates: US National Institutes of Health
Hepatocytic expression of human sodium-taurocholate cotransporting polypeptide enables hepatitis B virus infection of macaques
BJ Burwitz, JM Wettengel, MA Mück-Häusl, M Ringelhan, C Ko, ...
Nature communications 8 (1), 2146, 2017
Mandates: US National Institutes of Health, German Research Foundation
Lessons in nonhuman primate models for AIDS vaccine research: from minefields to milestones
JD Lifson, NL Haigwood
Cold Spring Harbor perspectives in medicine 2 (6), a007310, 2012
Mandates: US National Institutes of Health
SIV infection of rhesus macaques of Chinese origin: a suitable model for HIV infection in humans
Y Zhou, R Bao, NL Haigwood, Y Persidsky, W Ho
Retrovirology 10, 1-10, 2013
Mandates: US National Institutes of Health
Emergence of broadly neutralizing antibodies and viral coevolution in two subjects during the early stages of infection with human immunodeficiency virus type 1
DN Sather, S Carbonetti, DC Malherbe, F Pissani, AB Stuart, AJ Hessell, ...
Journal of virology 88 (22), 12968-12981, 2014
Mandates: US National Institutes of Health
Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre-and post-highly active antiretroviral therapy …
C Farquhar, D Wamalwa, S Selig, G John-Stewart, J Mabuka, M Majiwa, ...
The Pediatric infectious disease journal 28 (4), 295-299, 2009
Mandates: US National Institutes of Health
Animal models in HIV-1 protection and therapy
AJ Hessell, NL Haigwood
Current Opinion in HIV and AIDS 10 (3), 170-176, 2015
Mandates: US National Institutes of Health, National Institute for Health Research, UK
Achieving potent autologous neutralizing antibody responses against tier 2 HIV-1 viruses by strategic selection of envelope immunogens
AJ Hessell, DC Malherbe, F Pissani, S McBurney, SJ Krebs, M Gomes, ...
The Journal of Immunology 196 (7), 3064-3078, 2016
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program